Akebia Therapeutics
AKBA
AKBA
176 hedge funds and large institutions have $338M invested in Akebia Therapeutics in 2025 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 65 increasing their positions, 40 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5.42% more ownership
Funds ownership: 41.23% → 46.64% (+5.4%)
14% less capital invested
Capital invested by funds: $394M → $338M (-$56.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
176
Holding in Top 10
–
Calls
$2.11M
Puts
$1.21M
Top Buyers
| 1 | +$12.8M | |
| 2 | +$10M | |
| 3 | +$6.71M | |
| 4 |
Citigroup
New York
|
+$5.93M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$4.96M |
Top Sellers
| 1 | -$7.23M | |
| 2 | -$7.21M | |
| 3 | -$5.29M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$3.64M |
| 5 |
Morgan Stanley
New York
|
-$3.41M |
